RADIFUSION: A multi-radiomics deep learning based breast cancer risk prediction model using sequential mammographic images with image attention and bilateral asymmetry refinement
This provides an incremental improvement in risk assessment for clinicians, potentially aiding early detection in breast cancer screening.
The study tackled breast cancer risk prediction by developing RADIFUSION, a deep learning model that uses sequential mammograms with attention and asymmetry refinement, achieving AUCs of 0.905, 0.872, and 0.866 for 1-year, 2-year, and >2-year predictions on a test set of 1,749 women.
Breast cancer is a significant public health concern and early detection is critical for triaging high risk patients. Sequential screening mammograms can provide important spatiotemporal information about changes in breast tissue over time. In this study, we propose a deep learning architecture called RADIFUSION that utilizes sequential mammograms and incorporates a linear image attention mechanism, radiomic features, a new gating mechanism to combine different mammographic views, and bilateral asymmetry-based finetuning for breast cancer risk assessment. We evaluate our model on a screening dataset called Cohort of Screen-Aged Women (CSAW) dataset. Based on results obtained on the independent testing set consisting of 1,749 women, our approach achieved superior performance compared to other state-of-the-art models with area under the receiver operating characteristic curves (AUCs) of 0.905, 0.872 and 0.866 in the three respective metrics of 1-year AUC, 2-year AUC and > 2-year AUC. Our study highlights the importance of incorporating various deep learning mechanisms, such as image attention, radiomic features, gating mechanism, and bilateral asymmetry-based fine-tuning, to improve the accuracy of breast cancer risk assessment. We also demonstrate that our model's performance was enhanced by leveraging spatiotemporal information from sequential mammograms. Our findings suggest that RADIFUSION can provide clinicians with a powerful tool for breast cancer risk assessment.